Oxaprozin - CAS 21256-18-8
Catalog number:
21256-18-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H15NO3
Molecular Weight:
293.32
COA:
Inquire
Targets:
Cox-2
Description:
A inhibitor of both COX-1 and COX-2
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
A inhibitor of both COX-1 and COX-2
Appearance:
White Solid
Synonyms:
4,5-diphenyl-2-oxazolepropionic acid; Apo-Oxaprozin; Danoprox; Daypro; Dayrun; Rhoxal-oxaprozin ; Wy-21,743
Solubility:
DMSO 59 mg/mL (201.14 mM); Ethanol 27 mg/mL (92.04 mM)
Storage:
3 years -20°C powder;6 months-80°C in solvent
MSDS:
Inquire
Quality Standard:
In-house
Quantity:
Grams-Kilos
Boiling Point:
467°C at 760 mmHg
Melting Point:
158-159°C
InChIKey:
OFPXSFXSNFPTHF-UHFFFAOYSA-N
InChI:
1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)
Canonical SMILES:
C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
1.Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.
Lopes-de-Araújo J1, Neves AR1, Gouveia VM1, Moura CC1, Nunes C2, Reis S1. Pharm Res. 2016 Feb;33(2):301-14. doi: 10.1007/s11095-015-1788-x. Epub 2015 Sep 9.
PURPOSE: Nanostructured Lipid Carriers (NLCs) loading oxaprozin were developed to address an effective drug packaging and targeted delivery, improving the drug pharmacokinetics and pharmacodynamics properties and avoiding the local gastric side-effects. Macrophages actively phagocyte particles with sizes larger than 200 nm and, when activated, over-express folate beta receptors - features that in the case of this work constitute the basis for passive and active targeting strategies.
2.Synthesis of extended oxazoles II: Reaction manifold of 2-(halomethyl)-4,5-diaryloxazoles.
Patil PC1, Luzzio FA1. Tetrahedron Lett. 2016 Feb 17;57(7):757-759.
2-(Halomethyl)-4,5-diphenyloxazoles are effective, reactive scaffolds which can be utilized for synthetic elaboration at the 2-position. Through substitution reactions, the chloromethyl analogue is used to prepare a number of 2-alkylamino-, 2-alkylthio- and 2-alkoxy-(methyl) oxazoles. The 2-bromomethyl analogue offers a more reactive alternative to the chloromethyl compounds and is useful in the C-alkylation of a stabilized (malonate) carbanion as exemplified by a concise synthesis of Oxaprozin.
3.Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.
Saxena A1, Balaramnavar VM, Hohlfeld T, Saxena AK. Eur J Pharmacol. 2013 Dec 5;721(1-3):215-24. doi: 10.1016/j.ejphar.2013.09.032. Epub 2013 Sep 25.
Nonsteroidal anti-inflammatory drugs (NSAIDs) may interfere with the anti-platelet activity of aspirin at the level of the platelet cyclooxygenase-1 (COX-1) enzyme. In order to examine the interference of common NSAIDs with the anti-platelet activity of aspirin the human platelet rich plasma from voluntary donors was used for arachidonic acid-induced aggregation and determination of thromboxane synthesis. Further, docking studies were used to explain the molecular basis of the NSAID/aspirin interaction. The experimental results showed that celecoxib, dipyrone (active metabolite), ibuprofen, flufenamic acid, naproxen, nimesulide, oxaprozin, and piroxicam significantly interfere with the anti-platelet activity of aspirin, while diclofenac, ketorolac and acetaminophen do not. Docking studies suggested that NSAIDs forming hydrogen bonds with Ser530, Arg120, Tyr385 and other amino acids of the COX-1 hydrophobic channel interfere with antiplatelet activity of aspirin while non interfering NSAIDs do not form relevant hydrogen bond interactions within the aspirin binding site.
4.Theoretical and vibrational studies of 4,5-diphenyl-2-2 oxazole propionic acid (oxaprozin).
Sagdinc SG1, Esme A. Spectrochim Acta A Mol Biomol Spectrosc. 2010 Apr;75(4):1370-6. doi: 10.1016/j.saa.2010.01.004. Epub 2010 Feb 1.
The molecular structure, linear and nonlinear optical properties, and electronic properties of 4,5-diphenyl-2-2 oxazole propionic acid (oxaprozin) as a monomer were investigated by using Hartree-Fock (HF) and density functional theory (DFT) calculations that used 6-31G(d,p) basis set. The first-order hyperpolarizability of oxaprozin (OXA) was found to be 1.117 x 10(-30) esu. The structure of oxaprozin dimer with HF/6-31G(d) level caused by the shifts of O-H and CO bands in the vibrational spectra of oxaprozin were also studied. Moreover, these calculated frequencies of oxaprozin dimer were compared with the solid FT-IR and FT-Raman spectra. The theoretical frequencies and infrared intensities were showed a good agreement with experimental data.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Cox-2 Products


CAS 116686-15-8 FK 3311

FK 3311
(CAS: 116686-15-8)

A selective COX-2 inhibitor

CAS 198470-85-8 Parecoxib Sodium

Parecoxib Sodium
(CAS: 198470-85-8)

The prodrug Parecoxib as well as its active metabolite val have a specific affinity to the cannabinoid (CB) receptor measured in CB1-expressing HEK 293 cells an...

CAS 13710-19-5 Tolfenamic Acid

Tolfenamic Acid
(CAS: 13710-19-5)

A COX-2 inhibitor with IC50 of 0.2 μM

CAS 74103-07-4 Ketorolac

Ketorolac
(CAS: 74103-07-4)

A non-selective COX inhibitor of COX-1 and COX-2 with IC50 of 1.23 μM and 3.50 μM, respectively

CAS 134729-13-8 COX2-IN-1

COX2-IN-1
(CAS: 134729-13-8)

COX2-IN-1 is a selective and inducible COX2 inhibitor (IC50= 0.24 μM) with anti-inflammatory and analgesic activities.

CAS 74711-43-6 Zaltoprofen

Zaltoprofen
(CAS: 74711-43-6)

An inhibitor of Cox-1 and Cox-2;A nonsteroidal anti-inflammatory drug

CAS 53716-49-7 Carprofen

Carprofen
(CAS: 53716-49-7)

A COX-2 inhibitor; A non-steroidal anti-inflammatory drug

Indomethacin heptyl ester
(CAS: 282728-47-6)

A potent, non-selective COX-2 inhibitor

CAS 61-68-7 Mefenamic Acid

Mefenamic Acid
(CAS: 61-68-7)

A competitive inhibitor of COX-1 and COX-2

N-(3-hydroxyphenyl)-Arachidonoyl amide
(CAS: 83718-75-4)

An irreversible COX-2 inhibitor

BTB 02472
(CAS: 1177728-24-3)

An active-site-targeting Cox-2 inhibitor

CAS 84-26-4 Rutaecarpine

Rutaecarpine
(CAS: 84-26-4)

Rutecarpine is a COX-2 inhibitor isolated from Euodia ruticarpa.

CAS 181695-72-7 Valdecoxib

Valdecoxib
(CAS: 181695-72-7)

A selective COX-2 inhibitor

CAY10404
(CAS: 340267-36-9)

A potent, selective COX-2 inhibitor

COX-2 Inhibitor II
(CAS: 181696-33-3)

A selective inhibitor of Cox-2

CAS 91714-93-1 Bromfenac Sodium

Bromfenac Sodium
(CAS: 91714-93-1)

A potent inhibitor of both COX-1 and COX-2

CAS 53164-05-9 Acemetacin

Acemetacin
(CAS: 53164-05-9)

COX inhibitor; A non-steroidal anti-inflammatory drug

CAS 162011-90-7 Rofecoxib

Rofecoxib
(CAS: 162011-90-7)

A COX-2 inhibitor( IC50s = 26 nM and > 50 µM in human osteosarcoma cells )

CAS 51146-56-6 (S)-(+)-Ibuprofen

(S)-(+)-Ibuprofen
(CAS: 51146-56-6)

Be capable of inhibiting cyclooxygenase (COX) at clinically relevant concentrations; As an enantiomer of (R)-(-)-Ibuprofen, it more potently inhibits COX activi...

CAS 51803-78-2 Nimesulide

Nimesulide
(CAS: 51803-78-2)

A selective COX-2 inhibitor

Chemical Structure

CAS 21256-18-8 Oxaprozin

Quick Inquiry

Verification code

Featured Items